My Experience with SARS-CoV-2, with a Focus on Testing

J Clin Microbiol. 2020 Jul 23;58(8):e01228-20. doi: 10.1128/JCM.01228-20. Print 2020 Jul 23.

Abstract

Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) got off to a slow start in the United States. In this commentary, I describe my experience with CoV disease 2019 (COVID-19), with a focus on being tested at the University of North Carolina-Chapel Hill Respiratory Diagnostic Center on its inaugural day.

Keywords: COVID-19; COVID-19 testing; SARS-CoV-2; molecular diagnostics.

MeSH terms

  • Academic Medical Centers
  • Betacoronavirus / isolation & purification*
  • COVID-19
  • COVID-19 Testing
  • Clinical Laboratory Techniques / methods*
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / virology
  • Diagnostic Services / organization & administration
  • Hospitals, University
  • Humans
  • North Carolina
  • Pandemics
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / virology
  • SARS-CoV-2